Susquehanna International Group
RLAY icon

Susquehanna International Group’s Relay Therapeutics RLAY Stock Holding History

Susquehanna International Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Sell
96,549
-50,609
-34% -$735K ﹤0.01% 6725
2026
Q1 		$1.46M Sell
147,158
-75,771
-34% -$678K ﹤0.01% 6953
2025
Q4 		$1.89M Buy
222,929
+86,040
+63% +$614K ﹤0.01% 5787
2025
Q3 		$715K Sell
136,889
-169,180
-55% -$645K ﹤0.01% 8144
2025
Q2 		$1.06M Buy
306,069
+49,286
+19% +$147K ﹤0.01% 7267
2025
Q1 		$673K Buy
256,783
+180,465
+236% +$707K ﹤0.01% 8244
2024
Q4 		$314K Buy
76,318
+33,930
+80% +$185K ﹤0.01% 9742
2024
Q3 		$300K Sell
42,388
-12,003
-22% -$89.7K ﹤0.01% 9605
2024
Q2 		$355K Sell
54,391
-9,329
-15% -$63.7K ﹤0.01% 9093
2024
Q1 		$529K Buy
63,720
+26,082
+69% +$254K ﹤0.01% 8370
2023
Q4 		$414K Sell
37,638
-177,137
-82% -$1.49M ﹤0.01% 9107
2023
Q3 		$1.81M Buy
214,775
+155,358
+261% +$1.67M ﹤0.01% 5327
2023
Q2 		$746K Sell
59,417
-195,480
-77% -$2.43M ﹤0.01% 7367
2023
Q1 		$4.2M Buy
254,897
+218,782
+606% +$3.92M ﹤0.01% 3711
2022
Q4 		$540K Sell
36,115
-69,038
-66% -$1.32M ﹤0.01% 7654
2022
Q3 		$2.35M Buy
105,153
+19,916
+23% +$437K ﹤0.01% 4604
2022
Q2 		$1.43M Buy
85,237
+10,357
+14% +$222K ﹤0.01% 5669
2022
Q1 		$2.24M Sell
74,880
-19,514
-21% -$473K ﹤0.01% 5219
2021
Q4 		$2.9M Buy
94,394
+39,328
+71% +$1.24M ﹤0.01% 4709
2021
Q3 		$1.74M Buy
55,066
+20,033
+57% +$674K ﹤0.01% 6157
2021
Q2 		$1.28M Sell
35,033
-47,966
-58% -$1.58M ﹤0.01% 7065
2021
Q1 		$2.87M Buy
82,999
+71,228
+605% +$3.09M ﹤0.01% 5068
2020
Q4 		$489K Buy
+11,771
New +$532K ﹤0.01% 8343

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Susquehanna International Group's RLAY Position: Q2 2026 in Review

Susquehanna International Group reduced its Relay Therapeutics (RLAY) stake by 34% in Q2 2026, selling an estimated $735K and leaving 96,549 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #6725.

Susquehanna International Group first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.2M in Q1 2023. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Susquehanna International Group held 96,549 shares of Relay Therapeutics worth $1.81M as of Q2 2026.
  • Susquehanna International Group sold 50,609 Relay Therapeutics shares in Q2 2026, an estimated $735K.
  • Relay Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #6725 holding.
  • Susquehanna International Group first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Susquehanna International Group's Relay Therapeutics position peaked at $4.2M in Q1 2023.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.